Gate Bioscience

Gate Bioscience is a preclinical biotechnology company that has created a small molecule drug called Molecular Gates. It aims to selectively eliminate the source of harmful extracellular proteins within cells and prevent their occurrence that leads to disease. The company integrates a privileged library of molecular gates, a set of customized secretion-focused assays and technologies, and deep expertise in secretory pathway biology to enable precise, rapid, and reproducible drug discovery, allowing physicians to address a wide range of diseases with a single therapeutic mechanism.